Showing results (1281-1290 of 1,717) with videos related to

Sort By:
Pageof 172
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2024
Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC)Ing Soo Tiong, Devendra K Hiwase, Emad Abro, et al.
Diseases of the Colon and Rectum|December 21, 2023
Anal Adenocarcinoma Treated in the Era of Total Neoadjuvant Therapy and Nonoperative ManagementYael Feferman, Roni Y Rosen, Selim Gebran, et al.
Blood Advances|January 28, 2025
ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APLHarry J Iland, John Reynolds, Alan V Boddy, et al.
Annals of Surgical Oncology|February 20, 2026
Incidence and Predictors of Neoplastic Diagnosis in Patients with a Clinically Abnormal AppendixTina Gowda, Nicole Aguirre, Mostafa Mohamed, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 1, 2023
Nonoperative management of the primary tumor in patients with unresectable stage IV colon cancer treated with systemic chemotherapy: Higher complication rates for left-sided colon tumorsFloris S Verheij, Jonathan B Yuval, Niels F M Kok, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 28, 2017
[Prediction of outcome in acute myeloid leukemia by measurement of WT1 expression as a basic marker of minimal residual disease]N Zhao, H Wei, Y Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 2, 2016
[Homoharringtonine in newly diagnosed acute promyelocytic leukemia treatment: a prospective, randomized controlled trial]Y Wang, B C Liu, H Wei, et al.
Pageof 172